April 18, 2017

Tecentriq (atezolizumab) was granted accelerated approval for the treatment of people with locally advanced or metastatic urothelial carcinoma who are not eligible for cisplatin chemotherapy.

April 18, 2017

In fact, J&J stated is now including the estimated impact of the Actelion transaction in its financial guidance.

April 18, 2017

Beyond offering STI and HIV testing, Walgreens also is furthering its commitment to supporting communities impacted by HIV through prevention and early detection services, as well as HIV continuing education for its pharmacists. 

April 14, 2017

Jennifer Cretu — most recently VP marketing and public relations — has been named SVP pharma services and marketing.

April 14, 2017

Giant supermarket operator Kroger views health and wellness as an area for long-term investment, a point underscored by its purchase last year of specialty pharmacy ModernHEALTH.

April 14, 2017

Study’s senior author observed that the new approach would not only be more responsive to the most urgent unmet medical needs — terminal illnesses that are currently untreatable — it could also greatly accelerate the drug development process.

April 11, 2017

Atul Kavthekar has more than 20 years of experience in finance, most recently serving as CFO at e-retailer LivingSocial from June 2015 to December 2016. 

April 7, 2017

Dr. Regina Benjamin served as Surgeon General from 2009-2013 under Pres. Barack Obama.

April 6, 2017

Retailer seeing bottom-line improvement driven by sequential growth in retail pharmacy adjusted script comps, sequential progress in sales trends in its specialty pharmacy business, front store margin expansion and strong holiday seasonal category sales, said CEO Mike Bloom.

April 4, 2017

Accreditation shows ACS has demonstrated a comprehensive commitment to quality care, improved processes and better patient outcomes.

April 3, 2017

The new alliance between Walgreens and PBM Prime Therapeutics will be led by Joel Wright as CEO. Another Walgreens veteran, Don Vidic, was named chief pharmacy and growth officer.

March 31, 2017

Retailer stated the loss of this contract does not affect the company’s 2017 financial results.

March 31, 2017

The company will be dispensing atopic dermatitis drug Dupixent (dupilumab) and the limited-distribution multiple sclerosis treatment Ocrevus (ocrelizumab).

March 31, 2017

The 80mg once-daily tablets are intended for the treatment of patients with metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer.

March 28, 2017

ORIEN Avatar fosters collaboration among key stakeholders in cancer research with the shared goal of discovering and developing novel therapies in clinical trials.

March 28, 2017

Dr. Ajit Shetty has 36 years of pharmaceutical industry experience, first joining Janssen Pharmaceutica in 1976.

March 27, 2017

Joint arrangement expected to allow Novartis to accelerate clinical development of new therapies for breast cancer and identify which patients will benefit most.

March 27, 2017

Paul Bisaro previously served as executive chairman of Allergan, and president, CEO and chairman of the board of Actavis.

March 21, 2017

Some of the difficult-to-treat conditions may include cancer, hepatitis B and C, HIV, rheumatoid arthritis and a host of other medical conditions requiring very specialized medications and therapy regimens.

March 17, 2017

The specialty pharmacy will dispense Kisqali, which was recently approved by the Food and Drug Administration. 

March 17, 2017

Patients taking Genentech drug can live an average of 2.47 years longer than those with best supportive care treatment, research concludes.

March 7, 2017

Mike Agostino will return as president to Amber Pharmacy as Aaron Wiese leaves the position to become Hy-Vee VP strategy/innovation. 

March 6, 2017

DSN examines chain pharmacy, including in-depth coverage of the specialty market, in this multi-page report.

March 6, 2017

Specialty and biotech medicines aimed at treating cancer, multiple sclerosis and rare diseases will dominate much of drug development in 2017 and beyond, one of the nation’s top specialty pharmacy providers concluded.